FDA Concerned With Side Effect of Oscient Drug
Armed with studies showing a high risk of skin rashes from Oscient Pharmaceuticals Corp.'s Factive antibiotic, regulators at the FDA have planned a meeting on the safety and efficacy of the...To view the full article, register now.
Already a subscriber? Click here to view full article